Skip to main content

People in the News: May 18, 2010

Premium

BioNanomatrix has named David Barker to serve on its board of directors. Barker was vice president and chief scientific officer at Illumina between 2000 and 2006, and before that he was VP and chief science advisor at Amersham Biosciences and VP of research and business development at Molecular Dynamics. He also serves on the boards of Cell Biosciences, Integrated Diagnostics, IntegenX, and NextBio, and he is an advisor to Illumina, GenVault, Diagnostics for the Real World, Helixis, BiOptix, and DNA Direct.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.